streptokinase

简明释义

英[ˌstreptəʊˈkaɪneɪs]美[ˌstreptoʊˈkaɪˌneɪs]

n. [生化] 链激酶；溶栓酶

英英释义

单词用法

同义词

反义词

例句

1.The fermented soybean streptokinase ofthe present invention after being treated may be produced into thrombus dissolving medicine and health food for preventing cardiac and cerebral vascular diseases.

本发明的豆豉溶栓酶经处理后可制成溶血栓类药品和预防心血管疾病的保健食品。

2.The key safety end point was severe or moderate bleeding according to the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) definition.

首要效力观察终点为基于“通用链激酶与t-PA针对冠脉闭塞（GUSTO）”定义的中度或重度的出血；

3.The fermented soybean streptokinase ofthe present invention after being treated may be produced into thrombus dissolving medicine and health food for preventing cardiac and cerebral vascular diseases.

本发明的豆豉溶栓酶经处理后可制成溶血栓类药品和预防心血管疾病的保健食品。

4.For patients with acute ischemic stroke, we recommend against streptokinase (Grade 1a).

急性缺血性卒中患者，推荐不用链激酶(1a级)。

5.Intrapleural streptokinase for pleural infection a step forward in managing pleural effusions?

胸膜腔内滴注链激酶治疗胸膜腔感染这是胸膜腔积液治疗的进步吗？

6.Streptokinase and urokinase are important in thrombolytics, and asparaginase is used as a cytostatic agent in the treatment of leukemia.

链激酶和尿激酶溶栓是重要的，是天冬酰胺酶在治疗白血病细胞生长剂。

7.Patients receiving streptokinase must be informed about the risk of bleeding.

接受链激酶治疗的患者必须被告知出血的风险。

8.Clinical trials have shown that streptokinase is effective in treating pulmonary embolism.

临床试验表明，链激酶在治疗肺栓塞方面是有效的。

9.The use of streptokinase is often accompanied by monitoring for potential allergic reactions.

使用链激酶时，通常需要监测潜在的过敏反应。

10.The doctor administered streptokinase to dissolve the blood clot in the patient's artery.

医生给病人注射了链激酶以溶解动脉中的血栓。

11.In cases of myocardial infarction, streptokinase can be a lifesaving treatment.

在心肌梗死的情况下，链激酶可以成为挽救生命的治疗方法。

作文

Streptokinase is an important enzyme used in the medical field, particularly in the treatment of certain types of heart attacks and strokes. This enzyme, derived from streptococci bacteria, plays a crucial role in breaking down blood clots. When a patient suffers from a myocardial infarction or a thrombotic stroke, timely intervention is essential to restore blood flow to the affected area. The administration of streptokinase can significantly improve the chances of recovery by dissolving the clot that is obstructing blood circulation.The mechanism of action of streptokinase involves converting plasminogen, an inactive precursor, into plasmin, which is an active enzyme that digests fibrin, a key component of blood clots. This process helps to clear the blockage in the blood vessels, allowing for improved oxygen delivery to the heart or brain tissues. However, it is important to note that streptokinase is most effective when administered within a few hours of the onset of symptoms, making rapid diagnosis and treatment critical.Despite its benefits, the use of streptokinase is not without risks. Patients may experience side effects such as bleeding complications, allergic reactions, or hypotension. Therefore, healthcare providers must carefully evaluate the risks and benefits before administering this treatment. Moreover, patients with a history of certain conditions, such as recent surgery or hemorrhagic stroke, may not be suitable candidates for streptokinase therapy.In addition to its applications in acute care settings, research continues to explore the potential uses of streptokinase in other medical conditions. For instance, scientists are investigating its role in treating peripheral artery disease and deep vein thrombosis. As our understanding of this enzyme grows, it may lead to new therapeutic strategies that could benefit a broader range of patients.Overall, streptokinase represents a significant advancement in the treatment of thrombotic events. Its ability to effectively dissolve clots has saved countless lives and continues to be a valuable tool in emergency medicine. As we move forward, it is essential to balance the benefits of streptokinase with the potential risks, ensuring that patients receive the safest and most effective care possible. Continued research and clinical trials will help refine its applications and enhance our understanding of how best to utilize this powerful enzyme in various medical contexts.

链激酶是一个重要的酶，广泛应用于医学领域，特别是在某些类型的心脏病发作和中风的治疗中。该酶来源于链球菌，起着分解血栓的关键作用。当患者遭受心肌梗死或血栓性中风时，及时干预对于恢复受影响区域的血流至关重要。通过使用链激酶，可以显著提高恢复的机会，因为它能够溶解阻碍血液循环的血栓。链激酶的作用机制是将一种无活性的前体——纤溶酶原转化为纤溶酶，这是一种可以消化纤维蛋白的活性酶，纤维蛋白是血栓的关键成分。这个过程有助于清除血管中的堵塞，使氧气更好地输送到心脏或大脑组织。然而，需要注意的是，链激酶在症状出现后的几个小时内使用效果最佳，因此快速的诊断和治疗至关重要。尽管有很多好处，但使用链激酶并非没有风险。患者可能会经历出血并发症、过敏反应或低血压等副作用。因此，医疗服务提供者必须在施用这种治疗之前仔细评估风险和收益。此外，最近接受过手术或出血性中风的患者可能不适合接受链激酶治疗。除了在急救环境中的应用外，研究还在继续探索链激酶在其他医疗条件下的潜在用途。例如，科学家们正在研究它在治疗外周动脉疾病和深静脉血栓症中的作用。随着我们对这种酶的理解不断加深，可能会导致新的治疗策略，从而使更多患者受益。总的来说，链激酶代表了治疗血栓事件的重要进展。它有效溶解血栓的能力挽救了无数生命，并继续成为急救医学中的宝贵工具。随着我们向前发展，平衡链激酶的好处与潜在风险至关重要，以确保患者获得最安全和最有效的护理。持续的研究和临床试验将有助于完善其应用，并增强我们对如何在各种医疗背景下最好地利用这种强大酶的理解。